Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder

Journal of Affective Disorders

Volumn 136, Issue 3, 2012, Pages 1174-1178

  Levkovitz, Yechiel ^a   Alpert, Jonathan E ^a   Brintz, Carrie E ^a   Mischoulon, David ^a   Papakostas, George I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cognitive function; Major depression; One carbon cycle; S adenosylmethionine

Indexed keywords

PLACEBO; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; COGNITIVE DEFECT; DRUG EFFECT; HUMAN; MAJOR DEPRESSION; META ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECALL; SELF CONCEPT; WORD RECOGNITION;

ADULT; ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; S-ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITORS;

EID: 84857368903     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.04.059     Document Type: Article

References (31)

1. American Psychiatric Association Task Force on DSM-IV: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 1994 American Psychiatric Association Washington, D.C
2. M.P. Austin, P. Mitchell, and G.M. Goodwin Cognitive deficits in depression: possible implications for functional neuropathology Br. J. Psychiatry 178 2001 200 206
3. T. Bottiglieri Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drug therapies in psychiatric and neurological disorders Expert Opin. Investig. Drugs 6 1997 417 426
4. T. Bottiglieri, M. Laundy, R. Martin, M.W. Carney, H. Nissenbaum, B.K. Toone, A.L. Johnson, and E.H. Reynolds S-adenosylmethionine influences monoamine metabolism Lancet 2 8396 1984 224
5. A.E. Castaneda, J. Suvisaari, M. Marttunen, J. Perälä, S.I. Saarni, T. Aalto-Setälä, H. Aro, S. Koskinen, J. Lönnqvist, and A. Tuulio-Henriksson Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity J. Affect. Disord. 110 2008 36 45
6. A. Chan, F. Tchantchou, V. Graves, R. Rozen, and T.B. Shea Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine J. Nutr. Health Aging 12 2008 252 261
7. C. Erb, and J. Klein Enhancement of brain choline levels by nicotinamide: mechanism of action Neurosci. Lett. 249 1998 111 114
8. M. Fava, L.M. Graves, F. Benazzi, M.J. Scalia, D.V. Iosifescu, J.E. Alpert, and G.I. Papakostas A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment J. Clin. Psychiatry 67 2006 1754 1759
9. M. Fava, D.V. Iosifescu, P. Pedrelli, and L. Baer Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire Psychother. Psychosom. 78 2009 91 97
10. S. Fennig, A. Mottes, G. Ricter-Levin, I. Treves, and Y. Levkovitz Everyday memory and laboratory memory tests: general function predictors in schizophrenia and remitted depression J. Nerv. Ment. Dis. 190 2002 677 682
11. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0) Biometrics Research Department 1995 New York State Psychiatric Institute New York, NY
12. W. Guy ECDEU Assessment Manual for Psychopharmacology, revised DHEW Pub. No. (ADM) 76-338. 1976 National Institute of Mental Health Rockville, MD
13. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
14. A. Hammer, and G. Ardel Cognitive functioning in major depression-a summary Frontier Hum. Neuroscience 3 26 2009 1 7
15. F. Hirata, and J. Axelrod Phospholipid methylation and biological signal transmission Science 209 1980 1082 1090
16. J. Jaeger, S. Berns, S. Uzelac, and S. Davis-Conway Neurocognitive deficits and disability in major depressive disorder Psychiatry Res. 145 2006 39 48
17. N. Kennedy, K. Foy, R. Sherazi, M. McDonough, and P. McKeon Long-term social functioning after depression treated by psychiatrists: a review Bipolar Disord. 9 2007 25 37
18. D. Mischoulon, and M. Fava Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence Am. J. Clin. Nutr. 76 2002 1158S 1161S
19. D. Mischoulon, and M. Fava Are nutritional supplements ready for prime time? J. Clin. Psychiatry 69 2008 1497 1498
20. G. Muccioli, A. Scordamaglia, S. Bertacco, and R. Di Carlo Effect of S-adenosyl-L-methionine on brain muscarinic receptors of aged rats Eur. J. Pharmacol. 227 1992 293 299
21. F. Panza, V. Frisardi, C. Capurso, A. D'Introno, A.M. Colacicco, G. Vendemiale, A. Capurso, and V. Solfrizzi Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease J. Alzheimers Dis. 16 2009 467 470
22. G.I. Papakostas, J.E. Alpert, and M. Fava S-adenosyl-methionine in depression: a comprehensive review of the literature Curr. Psychiatry Rep. 5 2003 460 466
23. Papakostas, B.I.; Mischoulon, D.; Shyu, I.; Alpert, J.E.; Fava, M.; in press. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors (SRIs) for SRI-non-responders with major depressive disorder: adouble-blind, randomized clinical trial. Am. J. Psychiatry.
24. R. Remington, A. Chan, J. Paskavitz, and T.B. Shea Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study Am. J. Alzheimers Dis. Other Demen. 24 2009 27 33
25. T.B. Shea, and A. Chan S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer's disease J. Alzheimers Dis. 13 2008 67 70
26. J.V. Taylor Tavares, W.C. Drevets, and B.J. Sahakian Cognition in mania and depression Psychol. Med. 33 2003 959 967
27. F. Tchantchou, M. Graves, D. Ortiz, A. Chan, E. Rogers, and T.B. Shea S-adenosyl methionine: a connection between nutritional and genetic risk factors for neurodegeneration in Alzheimer's disease J. Nutr. Health Aging 10 2006 541 544
28. M.H. Trivedi, E. Hollander, D. Nutt, and P. Blier Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression J. Clin. Psychiatry 69 2008 246 258
29. A.C. Williams, and D.B. Ramsden Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases Med. Hypotheses 65 2005 353 362
30. A.L. Williams, C. Girard, D. Jui, A. Sabina, and D.L. Katz S-adenosylmethionine (SAMe) as treatment for depression: a systematic review Clin. Invest. Med. 28 2005 132 139
31. J. Pavia, F. Martos, J.A. Gonzalez-Correa, A.J. Garcia, F. Rius, S. Laukkonen, and F.S. de la Cuesta Effect of S-adenosyl methionine on muscarinic receptors in young rats Life Sci. 60 1997 825 832